FDA Inspection
Parnell Pharmaceuticals, Inc.Parnell Pharmaceuticals, Inc. – FDA Inspection, Jun 12, 2026
Record Details
This FDA Inspection record concerns Parnell Pharmaceuticals, Inc., with an inspection on June 12, 2026, issued by the San Francisco District Office, covering medical devices & rad health.
- Inspection Date
- June 12, 2026
- Product Type
- Medical Devices & Rad Health
View Company Profile
ID · 1dffff54-253e-4fe8-bf35-1451f8e18c67
Inspection Facts
- Inspection number
- 1321704
- FDA center
- Medical Devices & Rad Health
- Project area
- Compliance: Devices
- Outcome
- Form 483 issued
FDA Citations
8- 21 CFR 803.17Lack of Written MDR Procedures
- ISO 13485:2016 Clause 4.1.2Risk-based approach not applied to QMS processes
- ISO 13485:2016 Clause 5.5.2Management representative does not have required responsibility and authority
- ISO 13485:2016 Clause 5.6.1Management review procedures not documented
- ISO 13485:2016 Clause 7.3.1Design and development procedures not documented
- ISO 13485:2016 Clause 7.4.1Procedures for purchasing process not documented
- ISO 13485:2016 Clause 8.2.2Complaint handling procedures lack required elements
- ISO 13485:2016 Clause 8.2.4Internal audit procedures not documented
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Parnell Pharmaceuticals, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 27, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Parnell Pharmaceuticals, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.